Israel Englander Krystal Biotech, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,600 shares of KRYS stock, worth $659,124. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,600

Previous 56,635 93.64%

Holding current value

$659,124

Previous $10.1 Million 93.44%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$153.12 - $183.64 $8.28 Million - $9.93 Million	-54,065 Reduced 95.46%	2,570 $471,000
Q1 2024 May 15, 2024	BUY	$108.01 - $179.35 $5.2 Million - $8.63 Million	48,114 Added 564.65%	56,635 $10.1 Million
Q4 2023 Feb 14, 2024	BUY	$96.0 - $128.29 $818,016 - $1.09 Million	8,521 New	8,521 $1.06 Million
Q4 2022 Feb 14, 2023	BUY	$63.14 - $79.9 $954,866 - $1.21 Million	15,123 New	15,123 $1.2 Million
Q2 2022 Aug 15, 2022	SELL	$48.93 - $73.47 $2.27 Million - $3.41 Million	-46,353 Reduced 75.46%	15,076 $990,000
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $1.46 Million - $3.23 Million	36,619 Added 147.6%	61,429 $4.3 Million
Q3 2021 Nov 15, 2021	SELL	$52.01 - $71.77 $38,175 - $52,679	-734 Reduced 2.87%	24,810 $1.3 Million
Q4 2020 Feb 16, 2021	BUY	$40.64 - $61.38 $755,091 - $1.14 Million	18,580 Added 266.8%	25,544 $1.53 Million
Q2 2020 Aug 14, 2020	BUY	$37.03 - $60.0 $257,876 - $417,840	6,964 New	6,964 $288,000
Q4 2019 Feb 14, 2020	SELL	$33.17 - $65.23 $462,854 - $910,219	-13,954 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$34.72 - $51.3 $3.68 Million - $5.44 Million	-105,975 Reduced 88.36%	13,954 $484,000
Q2 2019 Aug 15, 2019	BUY	$27.2 - $41.2 $43,982 - $66,620	1,617 Added 1.37%	119,929 $4.83 Million
Q2 2019 Aug 14, 2019	BUY	$27.2 - $41.2 $793,070 - $1.2 Million	29,157 Added 32.7%	118,312 $3.56 Million
Q1 2019 May 14, 2019	BUY	$19.86 - $32.9 $1.77 Million - $2.93 Million	89,155 New	89,155 $2.93 Million
Q3 2018 Nov 14, 2018	SELL	$14.43 - $21.0 $371,774 - $541,044	-25,764 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$8.99 - $15.26 $77,008 - $130,717	8,566 Added 49.81%	25,764 $383,000
Q1 2018 May 15, 2018	SELL	$8.61 - $11.74 $69,482 - $94,741	-8,070 Reduced 31.94%	17,198 $174,000
Q4 2017 Feb 14, 2018	BUY	$8.19 - $11.19 $206,944 - $282,748	25,268	25,268 $266,000

Others Institutions Holding KRYS

# of Institutions

278

Shares Held

24.9M

Call Options Held

270K

Put Options Held

172K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.7B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account